For Mathieu, how the diabetes community which includes patient advocates, clinicians, diabetes educators, and industry leaders talks about these medications could help healthcare providers recognize that the benefits may outweigh the risks for some people with type 1 diabetes
Keeping a journal of symptoms and potential triggers can help a person identify what may be causing their episodes
This is a physiological response, not a personal failureit demonstrates why sustainable weight management often requires ongoing pharmaceutical support alongside behavior change
Why Interpretation by a Walsh-Trained Physician Matters Walsh-Trained Physician Matters Methylation patterns are nuanced
Eli Lilly, the global pharmaceutical giant, said the Therapeutic Goods Administration had approved the use of its Mounjaro weight-loss drug to treat moderate-to-severe obstructive sleep apnoea in adults with obesity
Constipation affects many GLP-1 users